All Pharma articles – Page 14
-
NewsDrugs to face new NHS affordability test
NICE and NHS England consult on “budget impact test” for new treatments Test designed to mitigate impact of cost effective but highly expensive drugs on NHS England’s budget NICE also proposes cost effectiveness threshold for assessment of drugs for rare conditions The National Institute for Health and Care ...
-
Expert BriefingThe Commissioner: The road to reconfiguration
What NHS England isn’t telling you, and more indispensable weekly insight for commissioners, by Dave West
-
NewsExclusive: Charity loses legal challenge to NHS England drug decision
Hepatitis C Trust loses legal challenge to NHS England’s decision to cap access to new drugs for the disease Judge rules decision to roll out treatments via “monthly run rate” is “legitimate” and “rational” Charity argued that capping therapy approved as cost effective went against NICE rules The ...
-
HSJ KnowledgeRoundtable: Making the most of technology
Doing technology well involves negotiating multiple hurdles, from sceptical boards to lack of national direction, heard HSJ’s latest roundtable panel
-
NewsDH halts £170m cut to community pharmacy budget
A significant cut to community pharmacy budgets has been halted by the Department of Health, with further discussions now set to be held with the sector.
-
CommentFood, glorious food: can trust chiefs eat hospital meals for a week?
Andy Jones throws down a challenge to trust chief executives to share the same culinary experience as their patients…
-
Expert BriefingHSJ Catch Up: Judicial review and the Kernow climbdown
Your essential update on the week in health
-
NewsNHS England blames HIV legal action for new treatments delay
NHS England says it cannot guarantee funding for 18 new services until outcome of judicial review on HIV prevention Jonathan Fielden says legal action “preventing us confirming the new opportunities for so many” Charity behind judicial review insists delays “of the NHS’s own making” NHS England has blamed ...
-
NewsNHS England: Pharma transparency scheme ‘does not go far enough’
NHS England says pharma firms’ new transparency scheme ”does not go far enough” because it relies on voluntary disclosure by clinicians of payments received Health professionals and organisations received £340m from industry in 2015 NHS England urges companies to refuse to fund individuals who ‘decline to be transparent’ New measures ...
-
SupplementsSupplement: Patient safety back to the drawing board
Misunderstanding of what ‘human factors’ means often leads organisations to try to change their people rather than the processes
-
NewsBrexit: Fall in the pound could create extra £900m bill for NHS
Brexit could create extra £900m bill for the NHS as suppliers hike prices to protect themselves against slump in the pound Most NHS organisations buy products in the pound but at least half of goods originate outside the UK Procurement expert says NHS must take action to deliver the ...
-
NewsMinister calls for end to 'apartheid' between NHS and private sector
George Freeman calls for deeper relationship between NHS and private sector There needs to be “a debate about how we fund healthcare”, he says There is a “quiet revolution” in which patients are being allowed by technology to take “responsibility” for their care Floats idea of local areas being ...
-
CommentBeing transparent is simply the right thing
Transparency of disclosure of payments is an opportunity to look at how pharmaceutical companies operate
-
NewsCharity mulls legal challenge to hepatitis C policy
Hepatitis C Trust considering judicial review of NHS England’s decision to cap new treatments for the disease Charity argues the decision breaches principle that patients should get access to treatments approved as cost effective by NICE NHS England says removing cap would result in “dramatic offsetting cuts” elsewhere in ...
-
NewsStevens: NICE process makes it 'harder' to strike deals with pharma
Simon Stevens says NICE authorisation can make it “harder” to run a procurement for new drugs, because “implied price” set during appraisal NHS England chief executive says PPRS, NICE appraisals and NHS England commissioning need “aligning” Mr Stevens says inclusion of “affordability” in NICE process “a debate I expect ...
-
News'Transformational' drugs to get fast tracked to NHS
Accelerated access review will recommend small number of “transformational” drugs and devices fast tracked into NHS each year Richard Barker says arrival of new products needed to be “wired into the NHS budgeting process” Simon Stevens says pharmaceutical price regulation scheme, NICE appraisals and NHS England commissioning not “interacting ...
-
News'Meltdown' of £330m outsource contract disrupts primary care
£330m primary care support services contract relied on major cost reductions NHS England outsourced primary care support to Capita last summer GPs, pharmacists and optometrists complain about new centralised services Practices unpaid, vital stationary and medical equipment not being delivered Vital primary care support services are in “meltdown” ...
-
CommentNHS channel management strategy needs some resuscitation
Gordon Miles on how some of the urgent care plans proposed by NHS agencies have been tried elsewhere and failed
-
NewsNHS England faces court battle in drug discrimination claim
NHS England is accused of discriminating against teenager with narcolepsy Hundreds of patients already receive NHS funding for the drug sodium oxybate Department of Health also using public money to fund private prescriptions NHS England will appear at the High Court on Wednesday accused of discriminating against a ...
-
NewsNHS England reveals how it will prioritise new specialised treatments
NHS England outlines detailed methodology for choosing which specialised treatments to fund Methodology has been in development for 18 months after previous approach dropped because of fear of legal challenge National body accused of giving itself “wiggle room” to help it get grip of specialised commissioning costs NHS ...